Table 2.
Characteristics | Survivors (30) | Non-survivors (16) | p Value |
---|---|---|---|
Age (yr) | 49.23 ± 10.48 | 50.50 ± 8.56 | .680 |
Male/female, n (%) | 25/5 (83.3) | 15/1 (93.8) | .318 |
Initial systolic blood pressure (mm/Hg) | 108.57 ± 33.67 | 110.06 ± 35.28 | .888 |
Inotropic support at admission, n (%) | 11 (36.7) | 12 (75.0) | .029 |
Need for mechanical ventilation, n (%) | 7 (24.1) | 11 (68.8) | .005 |
Need for renal replacement therapy, n (%) | 6 (20.0) | 8 (50.0) | .048 |
AKI, n (%) | 24 (80.0) | 15 (93.8) | .464 |
Risk | 4 (16.7) | 5 (33.3) | |
Injury | 6 (25.0) | 5 (33.3) | |
Failure | 14 (58.3) | 5 (33.3) | |
Acute pancreatitis (%) | 6 (20.7) | 4 (25.0) | |
Total LODS score | 5.13 ± 4.04 | 8.56 ± 4.49 | .011 |
Probability of mortality based on the LODS score (%) | 28.08 ± 27.20 | 52.61 ± 32.65 | .009 |
Arterial pH | 7.01 ± 0.22 | 6.89 ± 0.27 | .115 |
Bicarbonate (mmol/L) | 4.73 ± 3.12 | 5.31 ± 4.39 | .606 |
BUN (mmol/L) | 30.82 ± 21.48 | 27.51 ± 15.92 | .591 |
Ceatinine (mmol/L) | 2.32 ± 1.73 | 2.17 ± 1.19 | .749 |
Lactate (mmol/L) | 13.05 ± 9.21 | 16.12 ± 7.46 | .315 |
Serum anion gap (AG) (mmol/L) | 40.46 ± 10.29 | 35.49 ± 9.14 | .112 |
Corrected AG (mmol/L) | 40.85 ± 9.84 | 37.51 ± 9.44 | .273 |
Prothrombin activity (%) | 64.10 ± 19.94 | 47.69 ± 20.10 | .012 |
Total bilirubin | 1.71 ± 1.19 | 2.06 ± 0.51 | .371 |
White blood cell (x103/mm3) | 9.70 ± 9.33 | 16.48 ± 16.13 | .077 |
Hemoglobin (g/dL) | 12.96 ± 3.05 | 12.06 ± 2.23 | .308 |
Platelet (×103/mm3) | 210.20 ± 102.26 | 119.75 ± 85.10 | .004 |
Albumin (g/dL) | 3.86 ± 0.83 | 3.19 ± 0.93 | .017 |
Amylase (U/L) | 157.56 ± 183.68 | 409.80 ± 674.88 | .073 |
Lipase (U/L) | 90.89 ± 120.47 | 144.00 ± 190.77 | .275 |
LDH (IU/L) | 501.69 ± 598.44 | 1520.52 ± 380.13 | .018 |
CRP (mg/L) | 18.26 ± 38.69 | 24.66 ± 49.81 | .654 |
LODS: Logistic organ dysfunction system.